21st century excitatory amino acid research: A Q & A with Jeff Watkins and Dick Evans.
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
15 10 2021
15 10 2021
Historique:
pubmed:
8
8
2021
medline:
5
2
2022
entrez:
7
8
2021
Statut:
ppublish
Résumé
In 1981 Jeff Watkins and Dick Evans wrote what was to become a seminal review on excitatory amino acids (EAAs) and their receptors (Watkins and Evans, 1981). Bringing together various lines of evidence dating back over several decades on: the distribution in the nervous system of putative amino acid neurotransmitters; enzymes involved in their production and metabolism; the uptake and release of amino acids; binding of EAAs to membranes; the pharmacological action of endogenous excitatory amino acids and their synthetic analogues, and notably the actions of antagonists for the excitations caused by both nerve stimulation and exogenous agonists, often using pharmacological tools developed by Jeff and his colleagues, they provided a compelling account for EAAs, especially l-glutamate, as a bona fide neurotransmitter in the nervous system. The rest, as they say, is history, but far from being consigned to history, EAA research is in rude health well into the 21st Century as this series of Special Issues of Neuropharmacology exemplifies. With EAAs and their receptors flourishing across a wide range of disciplines and clinical conditions, we enter into a dialogue with two of the most prominent and influential figures in the early days of EAA research: Jeff Watkins and Dick Evans.
Identifiants
pubmed: 34363811
pii: S0028-3908(21)00298-7
doi: 10.1016/j.neuropharm.2021.108743
pii:
doi:
Substances chimiques
Excitatory Amino Acids
0
Neurotransmitter Agents
0
Receptors, Glutamate
0
Types de publication
Interview
Langues
eng
Sous-ensembles de citation
IM
Pagination
108743Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.